10x Genomics, Inc. provided revenue guidance for the full year 2024. 10x Genomics expects full year 2024 revenue to be in the range of $670 million to $690 million, representing 8% to 12% growth over full year 2023 revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.36 USD | -2.98% | -5.79% | -54.68% |
05-07 | Bruker's NanoString Secures Patent Case Win in Germany | MT |
05-02 | North American Morning Briefing : Stock Futures -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.68% | 3.04B | |
-1.44% | 12.58B | |
+0.13% | 8.51B | |
-0.73% | 5.29B | |
+20.18% | 5.16B | |
-0.74% | 4.55B | |
+24.56% | 3B | |
+25.13% | 2.17B | |
-1.86% | 1.92B | |
+5.88% | 1.64B |
- Stock Market
- Equities
- TXG Stock
- News 10x Genomics, Inc.
- 10X Genomics, Inc. Provides Revenue Guidance for the Full Year 2024